Lipid-based formulations for oral administration of poorly water-soluble drugs

International Journal of Pharmaceutics

Volumn 453, Issue 1, 2013, Pages 215-224

  Mu, Huiling ^a   Holm, René ^a,b   Mul̈lertz, Anette ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

In vitro lipolysis; Lipid digestion; Lipid based drug delivery systems; Lipids; Lymphatic transport; Poorly water soluble drug

Indexed keywords

DIGESTION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID BASED FORMULATION; PRIORITY JOURNAL; REVIEW;

EID: 84884160665     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.054     Document Type: Review

References (123)

1. Abrams, L.S., Weintraub, H.S., Patrick, J.E., Mcguire, J.L., 1978. Comparative bioavailability of a lipophilic steroid. J. Pharm. Sci. 67, 1287-1290. (Pubitemid 9014471)
2. Amidon, G.L., Lennernas, H., Shah, V.P., Crison, J.R., 1995. A theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 12, 413-420.
3. Armand, M., 2007. Lipases and lipolysis in the human digestive tract: where do we stand? Curr. Opin. Clin. Nutr. Metab. Care 10, 156-164. (Pubitemid 46220307)
4. Basalious, E.B., Shawky, N., Badr-Eldin, S.M., 2010. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I. Development and optimization. Int. J. Pharm. 391, 203-211.
5. Caliph, S.M., Charman, W.N., Porter, C.J., 2000. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 89, 1073-1084.
6. Carrigan, P.J., Bates, T.R., 1973. Biopharmaceutics of drugs administered in lipid-containing dosage forms. 1. Gi-absorption of griseofulvin from an oil-in-water emulsion in rat. J. Pharm. Sci. 62, 1476-1479.
7. Cast, J., Hamilton, R.J., 1999. In: Hamilton, R.J., Cast, J. (Eds.), Spectral Properties of Lipids. CRC Press LLC, Boca Raton, pp. 1-19.
8. Castera, A., 1995. In: Sebedio, J.-L., Perkins, E.G. (Eds.), New Trends in Lipid and Lipoprotein Analyses. AOCS Press, Champaign, pp. 10-16.
9. Chakrabarti, S., Belpaire, F.M., 1978. Bioavailability of phenytoin in lipid containing dosage forms in rats. J. Pharm. Pharmacol. 30, 330-331. (Pubitemid 8334369)
10. Chakraborty, S., Shukla, D., Mishra, B., Singh, S., 2009. Lipid - an emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm. 73, 1-15.
11. Chapus, C., Sémériva, M., Bovier-Lapierre, C., Desnuelle, P., 1976. Mechanism of pancreatic lipase action. 1. Interfacial activation of pancreatic lipase. Biochemistry 15, 4980-4987.
12. Charman, W.N.A., Stella, V.J., 1986a. Effects of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT. Int. J. Pharm. 33, 165- 172.
13. Charman, W.N.A., Stella, V.J., 1986b. Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. Int. J. Pharm. 34, 175-178.
14. Christensen, J.O., Schultz, K., Mollgaard, B., Kristensen, H.G., Mullertz, A., 2004. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur. J. Pharm. Sci. 23, 287-296. (Pubitemid 39369884)
15. Christensen, K.L., Pedersen, G.P., Kristensen, H.G., 2001. Preparation of redispersible dry emulsions by spray drying. Int. J. Pharm. 212, 187-194. (Pubitemid 32119444)
16. Christie, W.W., 1985. Rapid separation and quantification of lipid classes by high performance liquid chromatography and mass (light-scattering) detection. J. Lipid Res. 26, 507-512. (Pubitemid 15099377)
17. Christophe, A.B., 2004. Digestion and absorption of glycerides. In: Katsuragi, Y., Yasukawa, T., Matsuo, N., Flickinger, B.D., Tokimitsu, I., Matlock, M.G. (Eds.), Diacylglycerol Oil. AOCS Press, Champaign, pp. 16-29.
18. Constantinides, P.P., 1995. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12, 1561-1572. (Pubitemid 26005509)
19. Cordle, R.A., Lowe, M.E., 1998. The hydrophobic surface of colipase influences lipase activity at an oil-water interface. J. Lipid Res. 39, 1759-1767. (Pubitemid 28411163)
20. Corveleyn, S., Remon, J.P., 1998. Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int. J. Pharm. 166, 65-74. (Pubitemid 28239740)
21. Craig, D.Q.M., Lievens, H.S.R., Pitt, K.G., Storey, D.E., 1993. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int. J. Pharm. 96, 147-155. (Pubitemid 23233280)
22. Dahan, A., Hoffman, A., 2007. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur. J. Pharm. Biopharm. 67, 96-105. (Pubitemid 46991342)
23. Date, A.A., Nagarsenker, M.S., 2007. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 329, 166-172. (Pubitemid 44937527)
24. Dixit, R.P., Nagarsenker, M.S., 2008a. Formulation and in vivo evaluation of selfnanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev. Ind. Pharm. 34, 1285-1296.
25. Dixit, R.P., Nagarsenker, M.S., 2008b. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur. J. Pharm. Sci. 35, 183-192.
26. Dollo, G., Le Corre, P., Guerin, A., Chevanne, F., Burgot, J.L., Leverge, R., 2003. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur. J. Pharm. Sci. 19, 273-280. (Pubitemid 36918420)
27. Drewe, J., Meier, R., Vonderscher, J., Kiss, D., Posanski, U., Kissel, T., Gyr, K., 1992. Enhancement of the oral absorption of cyclosporine in man. Br. J. Clin. Pharmacol. 34, 60-64.
28. Fatouros, D.G., Deen, G.R., Arleth, L., Bergenstahl, B., Nielsen, F.S., Pedersen, J.S., Mullertz, A., 2007. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm. Res. 24, 1844-1853. (Pubitemid 47389238)
29. Fatouros, D., Nielsen, F., Douroumis, D., Hadjileontiadis, L., Müllertz, A., 2008. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks. Eur. J. Pharm. Biopharm. 69, 887-898.
30. Fricker, G., et al., 2010. Phospholipids and lipid-based formulations in oral drug delivery. Pharm. Res. 27, 1469-1486.
31. Furlanetto, S., Cirri, M., Piepel, G., Mennini, N., Mura, P., 2011. Mixture experiment methods in the development and optimization of microemulsion formulations. J. Pharm. Biomed. Anal. 55, 610-617.
32. Gershanik, T., Benita, S., 2000. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50, 179-188. (Pubitemid 30326696)
33. Gershkovich, P., Qadri, B., Yacovan, A., Amselem, S., Hoffman, A., 2007. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220. Eur. J. Pharm. Sci. 31, 298-305. (Pubitemid 47079000)
34. Grove, M., Mullertz, A., Pedersen, G.P., Nielsen, J.L., 2007. Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state. Eur. J. Pharm. Sci. 31, 8-15. (Pubitemid 46601865)
35. Grove, M., Pedersen, G.P., Nielsen, J.L., Mullertz, A., 2005. Bioavailability of seocalcitol I: relating solubility in biorelevant media with oral bioavailability in rats - effect of medium and long chain triglycerides. J. Pharm. Sci. 94, 1830-1838. (Pubitemid 41360876)
36. Gursoy, R.N., Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58, 173-182. (Pubitemid 38479922)
37. Hamosh, M., 1979. Review - fat digestion in the newborn - role of lingual lipase and pre-duodenal digestion. Pediatr. Res. 13, 615-622. (Pubitemid 9150193)
38. Hamosh, M., Scow, R.O., 1973. Lingual lipase and its role in digestion of dietary lipid. J. Clin. Invest. 52, 88-95.
39. Han, S.F., Yao, T.T., Zhang, X.X., Gan, L., Zhu, C.L., Yua, H.Z., Gan, Y., 2009. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation. Int. J. Pharm. 379, 18-24.
40. Hargrove, J.T., Maxson, W.S., Wentz, A.C., 1989. Absorption of oral progesterone is influenced by vehicle and particle-size. Am. J. Obstet. Gynecol. 161, 948-951. (Pubitemid 19266207)
41. Hauss, D.J., 2007. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 59, 667-676. (Pubitemid 47285409)
42. Heinz, E., 1996. In: Christie, W.W. (Ed.), Advances in Lipid Methodology - Three. The Oily Press, Dundee, pp. 211-332.
43. Holm, R., Jensen, I.H.M., Sonnergaard, J., 2006a. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev. Ind. Pharm. 32, 1025-1032. (Pubitemid 44521820)
44. Holm, R., Porsgaard, T., Porter, C.J.H., Hoy, C.E., Edwards, G.A., Mullertz, A., Kristensen, H.G., Charman, W.N., 2006b. Lymphatic fatty acids in canine with pharmaceutical formulations containing structured triacylglycerols. Eur. J. Lipid Sci. Technol. 108, 714-722. (Pubitemid 44475605)
45. Holm, R., Porter, C.J.H., Edwards, G.A., Mullertz, A., Kristensen, H.G., Charman, W.N., 2003. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J. Pharm. Sci. 120, 91-97. (Pubitemid 37103236)
46. Julianto, T., Yuen, K.H., Noor, A.M., 2000. Improved bioavailability of vitamin E with a self emulsifying formulation. Int. J. Pharm. 200, 53-57. (Pubitemid 30177249)
47. Kalogeris, T.J., Monroe, F., DeMichele, S.J., Tso, P., 1996. Intestinal synthesis and lymphatic secretion of apolipoprotein A-IV vary with chain length of intestinally infused fatty acids in rats. J. Nutr. 126, 2720-2729. (Pubitemid 26376607)
48. Kaukonen, A.M., Boyd, B.J., Charman, W.N., Porter, C.J.H., 2004a. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly watersoluble drugs in triglyceride lipids. Pharm. Res. 21, 254-260. (Pubitemid 38221970)
49. Kaukonen, A.M., Boyd, B.J., Porter, C.J.H., Charman, W.N., 2004b. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res. 21, 245-253. (Pubitemid 38221969)
50. Kleberg, K., Jacobsen, F., Fatouros, D.G., Mullertz, A., 2010a. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity. J. Pharm. Sci. 99, 3522-3532.
51. Kleberg, K., Jacobsen, J., Mullertz, A., 2010b. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. J. Pharm. Pharmacol. 62, 1656-1668.
52. Kohli, K., Chopra, S., Dhar, D., Arora, S., Khar, R.K., 2010. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discovery Today 15, 958-965.
53. Kristensen, J., Jorgensen, H., Mu, H., 2006. Diacylglycerol oil does not affect portal vein transport of nonesterified fatty acids but decreases the postprandial plasma lipid response in catheterized pigs. J. Nutr. 136, 1800-1805. (Pubitemid 43973579)
54. Kuentz, M., 2011. Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects. J. Drug Deliv. Sci. Technol. 21, 17-26.
55. Kuentz, M., Wyttenbach, N., Kuhlmann, O., 2007. Application of a statistical method to the absorption of a new model drug from micellar and lipid formulations - evaluation of qualitative excipient effects. Pharm. Develop. Technol. 12, 275-283. (Pubitemid 47027069)
56. Larsen, A., Holm, R., Pedersen, M.L., Mullertz, A., 2008. Lipid-based formulations for danazol containing a digestible surfactant, labrafil m2125cs: in vivo bioavailability and dynamic in vitro lipolysis. Pharm. Res. 25, 2769-2777.
57. Larsen, A.T., Sassene, P., Mullertz, A., 2011. In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. Int. J. Pharm. 417, 245-255.
58. Lipinski, C.A., 2000. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44, 235-249. (Pubitemid 32239479)
59. Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25. (Pubitemid 27046991)
60. Liu, Y., Chen, Z.Q., Zhang, X., Feng, N.P., Zhao, J.H., Wu, S., Tan, R., 2010. An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug delivery system. Chem. Pharm. Bull. 58, 16-22.
61. Moffett, D.F., Moffett, S.B., Schauf, C.L., 1993. Human Physiology. Foundations & Frontiers, Mosby, Inc., St. Louis, Missouri.
62. Mohsin, K., 2012. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS Pharm. Sci. Tech. 13, 637-646.
63. Mu, H., 2005. Analysis of lipids by new hyphenated techniques. In: Akoh, C.C., Lai, O.M. (Eds.), Healthful Lipids. AOCS Press, Champaign, pp. 78-98.
64. Mu, H., Høy, C.-E., 2004. The digestion of dietary triacylglycerols. Prog. Lipid Res. 43, 105-133. (Pubitemid 37487986)
65. Mu, H., Kalo, P., Xu, X., Høy, C.-E., 2000. Chromatographic methods in the monitoring of lipase-catalyzed interesterification. Eur. J. Lipid Sci. Technol. 102, 202-211.
66. Mu, H., Høy, C.-E., 2000. Effect of medium-chain fatty acids on lymphatic absorption of essential fatty acids in specific structured lipids. Lipids 35, 83-89. (Pubitemid 30084634)
67. Mu, H., Porsgaard, T., 2005. The metabolism of structured triacylglycerols. Prog. Lipid Res. 44, 430-448. (Pubitemid 41613755)
68. Mu, H., Hoy, C.E., 2001. Intestinal absorption of specific structured triacylglycerols. J. Lipid Res. 42, 792-798. (Pubitemid 32507179)
69. Mueller, E.A., Kovarik, J.M., Vanbree, J.B., Grevel, J., Lucker, P.W., Kutz, K., 1994. Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulations. Pharm. Res. 11, 151-155. (Pubitemid 24040779)
70. Müllertz, A., Fatouros, D.G., Smith, J.R., Vertzoni, M., Reppas, C., 2012. Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo. Mol. Pharmacol. 9, 237-247.
71. Müllertz, A., Ogbonna, A., Ren, S., Rades, T., 2010. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J. Pharm. Pharmacol. 62, 1622-1636.
72. Nielsen, F.S., Petersen, K.B., Mullertz, A., 2008. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur. J. Pharm. Biopharm. 69, 553-562.
73. Pitzalis, P., Monduzzi, M., Krog, N., Larsson, H., Ljusberg-Wahren, H., Nylander, T., 2000. Characterization of the liquid-crystalline phases in the glycerol monooleate/diglycerol monooleate/water system. Langmuir 16, 6358-6365.
74. Porsgaard, T., Kansky, J., Mason, S., Mu, H., 2005. Size and number of lymph particles measured by particle sizer during absorption of structured oils in rats. Lipids 40, 273-279. (Pubitemid 40628265)
75. Porter, C.J., Trevaskis, N.L., Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6, 231-248. (Pubitemid 46344627)
76. Porter, C.J.H., Charman, S.A., Williams, R.D., Bakalova, M.V., Charman, W.N., 1996. Evaluation of emulsifiable glasses for the oral administration of cyclosporin in beagle dogs. Int. J. Pharm. 141, 227-237. (Pubitemid 26302928)
77. Porter, C.J.H., Kaukonen, A.M., Taillardat-Bertschinger, A., Boyd, B.J., O'Connor, J.M., Edwards, G.A., Charman, W.N., 2004. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J. Pharm. Sci. 93, 1110-1121. (Pubitemid 38529685)
78. Porter, C., Pouton, C.W., Cuine, J.F., Charman, W.N., 2008. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev 60, 673-691.
79. Pouton, C.W., 2000. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11, S93-S98.
80. Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29, 278-287. (Pubitemid 44740131)
81. Pouton, C., Porter, C.J., 2008. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60, 625-637.
82. Prestidge, C.A., Barnes, T.J., Lau, C.H., Barnett, C., Loni, A., Canham, L., 2007. Mesoporous silicon: a platform for the delivery of therapeutics. Expert Opin. Drug Deliv. 4, 101-110. (Pubitemid 46389909)
83. Rahman, M.A., Harwansh, R., Mirza, M.A., Hussain, S., Hussain, A., 2011. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review. Curr. Drug Deliv. 8, 330-345.
84. Rane, S.S., Anderson, B.D., 2008. What determines drug solubility in lipid vehicles: is it predictable? Adv. Drug Deliv. Rev 60, 638-656.
85. Ren, S., Mu, H.L., Alchaer, F., Chtatou, A., Müllertz, A., 2013. Optimization of self-nanoemulsifying drug delivery system for poorly water soluble drug using response surface methodology. Drug Develop. Ind. Pharm. 39, 799-806.
86. Sacchetti, M., Nejati, E., 2012. Prediction of drug solubility in lipid mixtures from the individual ingredients. AAPS Pharm. Sci. Tech. 13, 1103-1109.
87. Salonen, J., Lehto, V.P., 2008. Fabrication and chemical surface modification of mesoporous silicon for biomedical applications. Chem. Eng. J. 137, 162-172. (Pubitemid 351226634)
88. Sander, C., Holm, P., 2009. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS Pharm. Sci. Tech. 10, 1388-1395.
89. Sassene, P.J., Knopp, M.M., Hesselkilde, J.Z., Koradia, V., Larsen, A., Rades, T., Mullertz, A., 2010. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. J. Pharm. Sci. 99, 4982-4991.
90. Sémériva, M., Desnuelle, P., 1979. Pancreatic lipase and colipase. An example of heterogeneous biocatalysis. Adv. Enzymol. 48, 319-370.
91. Shimada, A., Ohashi, K., 2003. Interfacial and emulsifying properties of diacylglycerol. Food Sci. Tech. Res. 9, 142-147. (Pubitemid 37044195)
92. Shukla, D., Chakraborty, S., Singh, S., Mishra, B., 2011. Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications. Expert Opin. Drug Deliv. 8, 207-224.
93. Simovic, S., Barnes, T.J., Tan, A., Prestidge, C.A., 2012. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids. Nanoscale 4, 1220-1230.
94. Simovic, S., Hui, H., Song, Y.M., Davey, A.K., Rades, T., Prestidge, C.A., 2010. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles. J. Control. Release 143, 367-373.
95. Singh, A., Worku, Z.A., Van den Mooter, G., 2011. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin. Drug Deliv. 8, 1361-1378.
96. Singh, B., Bandopadhyay, S., Kapil, R., Singh, R., Katare, O.P., 2009a. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit. Rev. Ther. Drug Carrier Syst. 26, 427-521.
97. Singh, H., Ye, A.Q., Horne, D., 2009b. Structuring food emulsions in the gastrointestinal tract to modify lipid digestion. Prog. Lipid Res. 48, 92-100.
98. Small, D.M., 1968. A classification of biologic lipids based upon their interaction in aqueous systems. J. Am. Oil Chem. Soc. 45, 108-119.
99. Smith, L.J., Kaminsky, S., Dsouza, S.W., 1986. Neonatal fat digestion and lingual lipase. Acta Paediatr. Scand. 75, 913-918. (Pubitemid 17185102)
100. Strickley, R.G., 2004. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21, 201-230. (Pubitemid 38221966)
101. Taha, E.I., Samy, A.M., Kassem, A.A., Khan, M.A., 2005. Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharm. Dev. Tech. 10, 363-370. (Pubitemid 41291473)
102. Takeuchi, H., Sasaki, H., Niwa, T., Hino, T., Kawashima, Y., Uesugi, K., Ozawa, H., 1991. Redispersible dry emulsion system as novel oral dosage form of oily drugs - in vivo studies in beagle dogs. Chem. Pharm. Bull. 39, 3362-3364.
103. Tan, A., Davey, A.K., Prestidge, C.A., 2011. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib. Pharm. Res. 28, 2273-2287.
104. Tan, A., Simovic, S., Davey, A.K., Rades, T., Boyd, B.J., Prestidge, C.A., 2010. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Mol. Pharmacol. 7, 522-532.
105. Tan, A., Simovic, S., Davey, A.K., Rades, T., Prestidge, C.A., 2009. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J. Control. Release 134, 62-70.
106. Tanaka, T., et al., 2010. In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice. Int. J. Pharm. 402, 190-197.
107. Tang, B., Cheng, G., Gu, J.C., Xu, C.H., 2008. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discovery Today 13, 606-612.
108. Thomas, N., Holm, R., Müllertz, A., Rades, T., 2012a. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS). J. Control. Release 160, 25-32.
109. Thomas, N., Holm, R., Rades, T., Mullertz, A., 2012b. Characterising lipid lipolysis and its implication in lipid-based formulation development. AAPS J. 14, 860-871.
110. Thomas, N., Mullertz, A., Graf, A., Rades, T., 2012c. Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems. J. Pharm. Sci. 101, 1721-1731.
111. Trull, A.K., Tan, K.K.C., Tan, L., Alexander, G.J.M., Jamieson, N.V., 1994. Enhanced absorption of new oral cyclosporine microemulsion formulation, neoral, in liver-transplant recipients with external biliary diversion. Transplant. Proc. 26, 2977-2978. (Pubitemid 24329385)
112. Tso, P., 1985. Gastrointestinal digestion and absorption of lipid. Adv. Lipid Res. 21, 143-186.
113. Tso, P., 1994. Intestinal lipid absorption. In: Johnson, L.R. (Ed.), Physiology of the Gastrointestinal Tract. Raven Press, New York, pp. 1867-1907.
114. Tuleu, C., Newton, M., Rose, J., Euler, D., Saklatvala, R., Clarke, A., Booth, S., 2004. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J. Pharm. Sci. 93, 1495-1502. (Pubitemid 38725021)
115. Van Speybroeck, M., Williams, H.D., Nguyen, T.H., Anby, M.U., Porter, C.J.H., Augustijns, P., 2012. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier. Mol. Pharmacol. 9, 2750-2760.
116. Wakerly, M.G., Pouton, C.W., Meakin, B.J., Morton, F.S., 1986. Self-emulsification of vegetable oil-nonionic surfactant mixtures. In: Phenomena in Mixed Surfactant Systems. American Chemical Society, London242-255.
117. Wang, L.J., Dong, J.F., Chen, J., Eastoe, J.L., Li, X.F., 2009. Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface Sci. 330, 443-448.
118. Watanabe, H., Tokimitsu, I., 2004. Digestion and absorption of diacylglycerol. In: Katsuragi, Y., Yasukawa, T., Matsuo, N., Flickinger, B.D., Tokimitsu, I., Matlock, M.G. (Eds.), Diacylglycerol Oil. AOCS Press, Champaign, pp. 30-45.
119. Yanez, J.A., Wang, S.W.J., Knemeyer, I.W., Wirth, M.A., Alton, K.B., 2011. Intestinal lymphatic transport for drug delivery. Adv. Drug Deliv. Rev. 63, 923-942.
120. Yi, T., Wan, J.L., Xu, H.B., Yang, X.L., 2008. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur. J. Pharm. Biopharm. 70, 439-444.
121. Yu, L.X., et al., 2002. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19, 921-925. (Pubitemid 34804232)
122. Zangenberg, N.H., Mullertz, A., Kristensen, H.G., Hovgaard, L., 2001a. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur. J. Pharm. Sci. 14, 115-122. (Pubitemid 32737533)
123. Zangenberg, N.H., Mullertz, A., Kristensen, H.G., Hovgaard, L., 2001b. A dynamic in vitro lipolysis model. II. Evaluation of the model. Eur. J. Pharm. Sci. 14, 237-244. (Pubitemid 32884320)